Sicart Associates LLC Gilead Sciences, Inc. Transaction History

Sicart Associates LLC

$272 Million
Q3 2024

A detailed history of Sicart Associates LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Sicart Associates LLC holds 110,130 shares of GILD stock, worth $10.2 Million. This represents 3.4% of its overall portfolio holdings.

Number of Shares

110,130

Previous 110,130 -0.0%

Holding current value

$10.2 Million

Previous $7.56 Million 22.17%

% of portfolio

3.4%

Previous 3.03%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	SELL	$63.15 - $72.88 $116,196 - $134,099	-1,840 Reduced 1.64%	110,130 $7.56 Million
Q1 2024 May 02, 2024	SELL	$71.58 - $87.29 $120,970 - $147,520	-1,690 Reduced 1.49%	111,970 $8.2 Million
Q4 2023 Jan 19, 2024	SELL	$73.27 - $83.09 $110,271 - $125,050	-1,505 Reduced 1.31%	113,660 $9.21 Million
Q3 2023 Oct 25, 2023	SELL	$73.94 - $80.67 $12,939 - $14,117	-175 Reduced 0.15%	115,165 $8.63 Million
Q2 2023 Jul 28, 2023	SELL	$76.01 - $86.7 $479,243 - $546,643	-6,305 Reduced 5.18%	115,340 $8.89 Million
Q1 2023 May 09, 2023	SELL	$77.31 - $88.08 $1.69 Million - $1.92 Million	-21,850 Reduced 15.23%	121,645 $10.1 Million
Q4 2022 Jan 27, 2023	SELL	$62.32 - $89.47 $115,603 - $165,966	-1,855 Reduced 1.28%	143,495 $0
Q3 2022 Nov 01, 2022	SELL	$59.54 - $68.01 $1.46 Million - $1.67 Million	-24,550 Reduced 14.45%	145,350 $8.97 Million
Q2 2022 Aug 05, 2022	SELL	$57.72 - $65.01 $45,310 - $51,032	-785 Reduced 0.46%	169,900 $10.5 Million
Q1 2022 May 06, 2022	SELL	$57.92 - $72.58 $895,153 - $1.12 Million	-15,455 Reduced 8.3%	170,685 $10.1 Million
Q4 2021 Jan 31, 2022	SELL	$64.88 - $73.64 $24,654 - $27,983	-380 Reduced 0.2%	186,140 $13.7 Million
Q3 2021 Oct 22, 2021	SELL	$67.69 - $73.03 $468,414 - $505,367	-6,920 Reduced 3.58%	186,520 $13 Million
Q2 2021 Jul 23, 2021	SELL	$63.47 - $69.35 $86,319 - $94,315	-1,360 Reduced 0.7%	193,440 $13.3 Million
Q1 2021 May 10, 2021	BUY	$60.0 - $68.46 $174,000 - $198,533	2,900 Added 1.51%	194,800 $12.6 Million
Q4 2020 Jan 22, 2021	BUY	$56.65 - $64.55 $7.44 Million - $8.48 Million	131,410 Added 217.24%	191,900 $11.2 Million
Q3 2020 Oct 14, 2020	BUY	$62.1 - $78.08 $3.76 Million - $4.72 Million	60,490 New	60,490 $3.82 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sicart Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sicart Associates LLC with notifications on news.

Account

Sicart Associates LLC Gilead Sciences, Inc. Transaction History